They observed that METTL14 was significantly increased in renal biopsy samples from patients with FSGS and diabetic kidney disease, as well as in cultured human foot cells treated with Adriamycin or AGE in vitro. This evidence concerns the gene METTL14 and diabetic kidney disease.